Vascular pathology and the role of hyaluronan

TheScientificWorldJournal

Volumn 8, Issue , 2008, Pages 1116-1118

  Vigetti, Davide ^a   Viola, Manuela ^a   Karousou, Evgenia ^a   Genasetti, Anna ^a   Rizzi, Manuela ^a   Clerici, Moira ^a   Bartolini, Barbara ^a   Moretto, Paola ^a   De Luca, Giancarlo ^a   Passi, Alberto ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Aging; Aortic smooth muscle cells; CD44; Cell migration; erk1 2; Glycosaminoglycan; Restenosis

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PACLITAXEL; RAPAMYCIN;

AORTA MEDIA; ARTERIOSCLEROSIS; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DRUG ELUTING STENT; EXTRACELLULAR MATRIX; HUMAN; INTIMA; PROTEIN PHOSPHORYLATION; RESTENOSIS; SENESCENCE; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

AORTA; CELL MOVEMENT; CORONARY RESTENOSIS; HUMANS; HYALURONIC ACID; HYMECROMONE; VASCULAR DISEASES;

EID: 56749163338     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2008.145     Document Type: Article

References (22)

1. Mathers, C.D., Fat, D.M., Inoue, M., Rao, C., and Lopez, A.D. (2005) Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull. World Health Organ. 83, 171-177.
2. Davis, G.E. and Senger, D.R. (2005) Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97, 1093-1107.
3. Karamanos, N.K., Axelsson, S., Vanky, P., Tzanakakis, G.N., and Hjerpe, A. (1995) Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. J. Chromatogr. A 696, 295-305.
4. Spicer, A.P. and Tien, J.Y. (2004) Hyaluronan and morphogenesis. Birth Defects Res. C Embryo Today 72, 89-108.
5. Day, A.J. and Prestwich, G.D. (2002) Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277, 4585-4588.
6. Wight, T.N. (2008) Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front. Biosci. 13, 4933-4937.
7. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
8. Halayko, A. J. and Solway, J. (2001) Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J. Appl. Physiol. 90, 358-368.
9. Passi, A., Negrini, D., Albertini, R., Miserocchi, G., and De Luca, G. (1999) The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 456, 93-96.
10. Vigetti, D., Viola, M., Karousou, E., Rizzi, M., Moretto, P., Genasetti, A., Clerici, M., Hascall, V.C., De Luca, G., and Passi, A. (2008) Hyaluronan-CD44-erk1/2 regulate human aortic smooth muscle cell motility during aging. J. Biol. Chem. 283, 4448-4458.
11. Vigetti, D., Ori, M., Viola, M., Genasetti, A., Karousou, E., Rizzi, M., Pallotti, F., Nardi, I., Hascall, VC., De Luca, G., and Passi, A. (2006) Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J. Biol. Chem. 281, 8254-8263.
12. Vigetti, D., Moretto, P., Viola, M., Genasetti, A., Rizzi, M., Karousou, E., Pallotti, F., De Luca, G., and Passi, A.(2006) Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. FASEB J. 20(8), 1118-1130.
13. Riessen, R., Wight, T.N., Pastore, C., Henley, C., and Isner, J.M. (1996) Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93, 1141-1147.
14. Cuff, C.A., Kothapalli, D., Azonobi, I., Chun, S., Zhang, Y., Belkin, R., Yeh, C., Secreto, A., Assoian, R.K., Rader, D.J., and Pure, E. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108, 1031-1040.
15. Toole, B.P. (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539.
16. Savani, R.C., Wang, C., Yang, B., Zhang, S., Kinsella, M.G., Wight, T.N., Stern, R., Nance, D.M., and Turley, E.A. (1995) Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin. Invest. 95, 1158-1168.
17. Gouëffic, Y., Guilluy, C., Guérin, P., Patra, P., Pacaud, P., and Loirand, G. (2006) Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc. Res. 72, 339-344.
18. Isacke, C.M. and Yarwood, H. (2002) The hyaluronan receptor, CD44. Int. J. Biochem. Cell Biol. 34, 718-721.
19. Nakamura, T., Takagaki, K., Shibata, S., Tanaka, K., Higuchi, T. and Endo, M. (1995) Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem. Biophys. Res. Commun. 208, 470-475.
20. Parry, T.J., Brosius, R., Thyagarajan, R., Carter, D., Argentieri, D., Falotico, R., and Siekierka, J. (2005) Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur. J. Pharmacol. 524, 19-29.
21. Gouëffic, Y., Potter-Perigo, S., Chan, C.K., Johnson, P.Y., Braun, K., Evanko, S.P., and Wight, T.N. (2007) Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM. Atherosclerosis 195, 23-30.
22. Wilkinson, T.S., Bressler, S.L., Evanko, S.P., Braun, K.R., and Wight, T.N. (2006) Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J. Cell. Physiol. 206(2), 378-385.